09.27.23
ExxonMobil has selected the industry expertise and market presence of JL Goor to help drive growth in the Ireland and United Kingdom (U.K.) healthcare sector, building on an existing well-regarded long-term relationship.
JL Goor will have access to ExxonMobil's broad healthcare portfolio which can provide the building blocks to engineer a range of applications including medical supplies, infection protection products, and pharmaceutical and laboratory supplies. The portfolio includes Vistamaxx performance polymers, ExxonMobil polypropylene (PP), Exact polyolefin elastomers, and Achieve Advanced PP which are designed to meet changing healthcare market needs for healthy, safe material options.
"The Ireland and UK healthcare sector plays an important role in the broader European market," says Gertrud Masure, ExxonMobil's market development manager for polypropylene, Vistamaxx and Exact, EMEAF. "With Ireland serving as a large supplier for medical devices and electronics, ExxonMobil has made a decision to support its dedicated healthcare team by harnessing the expertise of JL Goor to help drive market growth in the region."
The collaboration with JL Goor will broaden the accessibility of ExxonMobil's healthcare portfolio across the whole of the industry. In particular, interest in Vistamaxx for medical and pharmaceutical applications has increased significantly, partially due to a move by the industry to replace polyvinyl chloride (PVC), but also due to its unique mechanical properties which deliver elasticity, high impact, and flexibility. Vistamaxx is well suited to replacing PVC in applications such as IV bags, tubes, ostomy pouches and bio reactor bags.
"Building on a successful long term relationship with ExxonMobil, we are delighted it has been extended to the healthcare sector," says Gearoid Clarke, JL Goor Materials managing director. "The Vistamaxx MED products, which were introduced at the end of last year, and ExxonMobil PP Med products will add significantly to, and complement, our existing medical portfolio, strengthening our already strong supply position in a market we understand, value and are committed to.”
JL Goor was selected because of its reputation as a leader in the Ireland and U.K. healthcare industry and ExxonMobil believes that by working together the full market potential for its healthcare polymer portfolio can be achieved.
“Having played an important role in the healthcare industry for many years, ExxonMobil is committed to fulfilling the potential in this sector," says Kateline Rooze, ExxonMobil's regional sales manager. "The expertise of JL Goor will play a key role in helping to build market and brand awareness for our healthcare portfolio. ExxonMobil is supporting expected increases in demand with new Vistamaxx and PP assets.”
JL Goor will have access to ExxonMobil's broad healthcare portfolio which can provide the building blocks to engineer a range of applications including medical supplies, infection protection products, and pharmaceutical and laboratory supplies. The portfolio includes Vistamaxx performance polymers, ExxonMobil polypropylene (PP), Exact polyolefin elastomers, and Achieve Advanced PP which are designed to meet changing healthcare market needs for healthy, safe material options.
"The Ireland and UK healthcare sector plays an important role in the broader European market," says Gertrud Masure, ExxonMobil's market development manager for polypropylene, Vistamaxx and Exact, EMEAF. "With Ireland serving as a large supplier for medical devices and electronics, ExxonMobil has made a decision to support its dedicated healthcare team by harnessing the expertise of JL Goor to help drive market growth in the region."
The collaboration with JL Goor will broaden the accessibility of ExxonMobil's healthcare portfolio across the whole of the industry. In particular, interest in Vistamaxx for medical and pharmaceutical applications has increased significantly, partially due to a move by the industry to replace polyvinyl chloride (PVC), but also due to its unique mechanical properties which deliver elasticity, high impact, and flexibility. Vistamaxx is well suited to replacing PVC in applications such as IV bags, tubes, ostomy pouches and bio reactor bags.
"Building on a successful long term relationship with ExxonMobil, we are delighted it has been extended to the healthcare sector," says Gearoid Clarke, JL Goor Materials managing director. "The Vistamaxx MED products, which were introduced at the end of last year, and ExxonMobil PP Med products will add significantly to, and complement, our existing medical portfolio, strengthening our already strong supply position in a market we understand, value and are committed to.”
JL Goor was selected because of its reputation as a leader in the Ireland and U.K. healthcare industry and ExxonMobil believes that by working together the full market potential for its healthcare polymer portfolio can be achieved.
“Having played an important role in the healthcare industry for many years, ExxonMobil is committed to fulfilling the potential in this sector," says Kateline Rooze, ExxonMobil's regional sales manager. "The expertise of JL Goor will play a key role in helping to build market and brand awareness for our healthcare portfolio. ExxonMobil is supporting expected increases in demand with new Vistamaxx and PP assets.”
